ClinVar Miner

Submissions for variant NM_000051.3(ATM):c.3614G>A (p.Arg1205His) (rs769106895)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000227875 SCV000282935 uncertain significance Ataxia-telangiectasia syndrome 2019-12-08 criteria provided, single submitter clinical testing This sequence change replaces arginine with histidine at codon 1205 of the ATM protein (p.Arg1205His). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs769106895, ExAC 0.009%). This variant has been observed in individuals with personal or family history of breast and/or ovarian cancer (PMID: 30287823). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000486877 SCV000569511 uncertain significance not provided 2018-12-13 criteria provided, single submitter clinical testing This variant is denoted ATM c.3614G>A at the cDNA level, p.Arg1205His (R1205H) at the protein level, and results in the change of an Arginine to a Histidine (CGT>CAT). This variant was observed in three individuals with breast cancer as well as in unaffected controls (Momozawa 2018). ATM Arg1205His was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is located in the region of interaction with beta-adaptin (Tavtigian 2009). In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether ATM Arg1205His is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Ambry Genetics RCV000569109 SCV000665259 likely benign Hereditary cancer-predisposing syndrome 2018-04-27 criteria provided, single submitter clinical testing Other strong data supporting benign classification;In silico models in agreement (benign)
GeneKor MSA RCV000569109 SCV000821850 uncertain significance Hereditary cancer-predisposing syndrome 2018-08-01 criteria provided, single submitter clinical testing
Color RCV000569109 SCV000903866 likely benign Hereditary cancer-predisposing syndrome 2016-04-08 criteria provided, single submitter clinical testing
Cancer Genomics Group,Japanese Foundation For Cancer Research RCV001030527 SCV001193475 uncertain significance Hereditary breast and ovarian cancer syndrome 2019-05-01 criteria provided, single submitter research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.